Companion diagnostics (CDx), positioned at the intersection of pathology, drug development, and patient access, have emerged ...
According to Verified Market Research®, the global Metabolomics Market Report was valued at USD 3.7 Billion in 2024 and is projected to reach USD 7.4 Billion by 2032, growing at a CAGR of 2.3% during ...
The global immunohistochemistry market is projected to grow at 6.78% CAGR through 2031, supported by increasing cancer prevalence, expanding use of biomarker-based diagnostics, and strong demand ...
BFI’s $50M innovation full stack to accelerate India’s medtech ecosystem: Our Bureau, Bengaluru Friday, April 10, 2026, 17:30 Hrs [IST] Blockchain For Impact (BFI) has launche ...
KNOXVILLE, TN, UNITED STATES, April 7, 2026 /EINPresswire.com/ -- Daisy Genomics Inc. (“Daisy Genomics”), a precision ...
Profusa expands into molecular diagnostics through a LoI to acquire the PanOmics multi-omics diagnostics platform from BioInsights: Berkeley, California Tuesday, April 7, 2026, 16 ...
Company secures scalable multi-omics diagnostics platform and launches Mayo Clinic partnership adding to Lumee real-time biochemistry monitoring ...
Partnership combines Lunit's platform-agnostic AI pathology algorithms with CellCarta's global CDx development and laboratory execution to help biopharma teams de-risk assets and accelerate evidence ...
"Currently, China's healthcare security data covers over 1.33 billion insured individuals, forming the world's largest and ...
Veteran biotech investor to steer IBC’s impact fund targeting early-stage therapies, diagnostics, and technologies for ...
Integrated consulting approach streamlines pathway from concept to commercialization NEW YORK, NY, UNITED STATES, April ...
As Vietnam advances national digital health initiatives, connected diagnostic tools are becoming increasingly important. Kardia 12L now strengthens AliveCor's cardiovascular portfolio by standing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results